Company
Decisions in the clinic
Overview
Brainscore Coma
Drug development
Newsroom
Join us
Contact
News
11 January 2023
BrainTale has presented the interest if its digital biomarkers platform in differential diagnosis during the 15th edition of Clinical Trials on Alzheimer’s Disease conference
5 September 2022
American Academy of Neurology (AAN 2022) – Braintale showcases together with Minoryx data from its biomarker platform for disease and treatment monitoring of X-linked Adrenoleukodystrophy and strengthens collaboration
7 April 2022
French Grand Est region: Braintale presents promising results on Amyotrophic Lateral Sclerosis and announces a partnership with the University Hospitals of Strasbourg
